Category: Biomarkers
   
   Biomarker-Driven Research: Transforming Treatments for Rare Cancers  Reassessing the classification of rare cancer types Historically, research on rare cancers centered around tumor  Read Now   
   Reflections from ESMO 2025  Progress, Breakthrough Science and the Future of Oncology We were delighted to attend the recent  Read Now   
   The Resurgence of Antibody-drug Conjugates  How ADCs are redefining cancer therapy Cancer treatment is undergoing a transformation, fueled by advances  Read Now   
   Advancing Lung Cancer Trials with Precision  Lung cancer is the second most diagnosed cancer and the leading cause of cancer-related deaths  Read Now   
   Key Takeaways from World ADC 2024  The resurgence of ADCs in cancer therapy The World ADC conference is the leading conference  Read Now   
   Highlights from HubXchange Immunotherapies Maryland 2024  Optimizing dose and leveraging biomarkers for enhanced patient safety in immunotherapy trials HubXchange Immunotherapies brought  Read Now